Hovione Technology’s 8Shot™ inhaler chosen as finalist of Medical Design Excellence Award

April 14th, 2021

Hovione Technology, a pharmaceutical specialist in innovative pulmonary device technology, announced today its new 8Shot™ Dry Powder Inhaler (DPI) has been chosen as finalist in the Drug-Delivery and Combination Products category of the 2021 Medical Design Excellence Awards (MDEA) competition. MDEA is a division of UK-based multinational Informa plc.

 "The MDEA competition is a premier awards program for the medtech industry. The selection of our 8Shot™ DPI to be among the list of finalists in the Drug-Delivery and Combination products category is a great achievement for the Hovione Technology team”, said Peter Villax, Hovione Technology’s CEO.

 The 8Shot™ DPI is a high drug load inhaler specially designed to deliver inhaled vaccines, anti-virals, antibiotics and biologics requiring very high dose drug delivery and provides the largest delivery capability in the industry without compromising simplicity. It achieves ease of use by  patients by breaking down the delivery to the lung of the total drug dose in multiple inhalation steps for maximum therapeutic benefit and patient comfort.

 "We are honored and delighted to be a finalist of the MDEA competition, together with our design and development partner WeADD”, said Dr João Ventura Fernandes, Hovione Technology’s Director of Technology Development and Licensing. "This nomination recognizes our medical product design efforts with the 8Shot™ DPI to make it as attractive and as easy to use as possible to patients, a necessary step to regular use and treatment compliance.”

 "We are very happy to be nominated as MDEA finalist together with Hovione Technology. This is a result of a fruitful long-term collaboration between our two companies in the design and development of medical device products”, said Agostinho Carvalho, WeADD CEO. "The 8Shot™ DPI offers a unique, patient friendly inhaler design and makes available a patented high payload DPI to pharmaceutical companies, off-the-shelf, ready to support their developments”.

 For further information, please contact info@hovionetechnology.com

Download:Full press release(145.47 KB)
Cookie Policy
This site uses cookies. When browsing the site, you are consenting its use.
Learn more
I understood